Covington Guides Emergent's $270M Vaccine Biz Buy
Emergent BioSolutions Inc. on Thursday said it has agreed to acquire a specialty vaccine company from Cerberus Capital Management LP and Ignition Growth Capital for $270 million, in a deal that...To view the full article, register now.
Already a subscriber? Click here to view full article